Kadmus KDS-4103 Pages on BioPortfolio:

BioPortfolio - kadmus kds-4103
BioPortfolio - Kadmus KDS-4103 Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). ... In vitro, KDS-4103 inhibits FAAH activity with ...
http://www.bioportfolio.com/search/kadmus_kds-4103.html...

BioPortfolio - KADMUS
Kadmus Pharmaceuticals Entry on Bioportfolio's Biocorporate Database ... kadmus kds4103 BioPortfolio kadmus kds4103 Pages on BioPortfolio KDS4103 which was ...
http://www.bioportfolio.com/search/KADMUS.html...

BioPortfolio - Kadmus Pharmaceuticals
technology from Kadmus Pharmaceuticals Inc. The. acquisition includes KDS-4103 (URB-597), a lead FAAH. inhibitor program for CNS disorders; . ...
http://www.bioportfolio.com/search/Kadmus_Pharmaceuticals.ht...

BioPortfolio - kadmus pharmaceutical
such as URB-597 (11, KDS-4103; Kadmus Pharmaceuticals. Inc; Figure 7) which was invented and patented jointly by. the Universities of California, . ...
http://www.bioportfolio.com/search/kadmus_pharmaceutical.htm...

BioPortfolio - kadmus pharma
BioPortfolio - kadmus kds-4103 Recent Publications by Kadmus Pharmaceuticals. • Pharmacological profile of the selective FAAH inhibitor KDS4103URB597. ...
http://www.bioportfolio.com/search/kadmus_pharma.html...

BioPortfolio - Kadmus Pharmaceuticals
Recent Publications by Kadmus Pharmaceuticals:. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). In the present article, ...
http://www.bioportfolio.com/biocorporate/5988-Kadmus_Pharmac...

Results from other life science and pharmaceutical sites:

Non-linear enzymatic logic in natural product modular mega ...
based on the development of KDS-4103 and any other. follow-on compounds. KDS- 4103, which was originally. licensed to Kadmus from the University of ...
http://www.biomedcentral.com/content/pdf/cd-827283.pdf...

cd-827283 Review Licensing Highlights Bright J Shumoogam J Tear S ...
Kadmus is eligible to receive an upfront payment and future milestone payments 650 IDrugs 2007 Vol 10 No 9 based on the development of KDS-4103 and any ...
http://www.biomedcentral.com/content/download/xml/cd-827283....

Pharmacological profile of the selective FAAH inhi...[CNS Drug Rev ...
Kadmus Pharmaceuticals, Inc. Irvine, California 92697-4625, USA. piomelli@uci. edu ... In vitro, KDS-4103 inhibits FAAH activity with median inhibitory ...
http://www.ncbi.nlm.nih.gov/pubmed/16834756...

The endocannabinoid system: A drug discovery perspective Daniele ...
such as URB-597 (11, KDS-4103; Kadmus Pharmaceuticals. Inc; Figure 7) which was invented and patented jointly by. the Universities of California, ...
http://www.biomedcentral.com/content/pdf/cd-608185.pdf...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.